GLP1 Receptor Agonist Induced Guttate Psoriasis in an Adult Female
SKIN The Journal of Cutaneous Medicine · 07.10.2025 · 9 (3) · 2334-2338
DOI: 10.25251/skin.9.3.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 07.10.2025. Verfasst von Savannah Cook und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With increasing use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), it is important to recognize possible adverse effects. While most cutaneous GLP-1RAs side effects are related to injection site reactions, there are several documented instances of rare cutaneous effects. We present a novel case of tirzepatide-induced psoriasis resolved with risankizumab-rzaa treatment.
Zitieren
APA
Cook, S., & Selby, T. (2025). GLP1 Receptor Agonist Induced Guttate Psoriasis in an Adult Female. SKIN The Journal of Cutaneous Medicine, 9(3), 2334-2338. https://doi.org/10.25251/skin.9.3.9
Vancouver
Cook S, Selby T. GLP1 Receptor Agonist Induced Guttate Psoriasis in an Adult Female. SKIN The Journal of Cutaneous Medicine. 2025;9(3):2334-2338. doi:10.25251/skin.9.3.9
BibTeX
@article{Cook2025,
author = {Cook, Savannah and Selby, Thomas},
title = {GLP1 Receptor Agonist Induced Guttate Psoriasis in an Adult Female},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2025},
volume = {9},
number = {3},
pages = {2334--2338},
doi = {10.25251/skin.9.3.9}
}
EUVIMED